Stay updated on Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Sign up to get notified when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.

Latest updates to the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedMajor change: updated operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference11%

- Check27 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%

- Check42 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2, and the Back to Top control was removed. No substantive changes to core content or key information were detected.SummaryDifference0.6%

- Check49 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.7%

- Check56 days agoChange DetectedThe web page has added a facility name and location details while removing specific state, country, and city information. This indicates a shift towards a more generalized presentation of location data.SummaryDifference25%

- Check70 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%

Stay in the know with updates to Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.